Oriol Mirallas/X
May 30, 2025, 23:58
Oriol Mirallas: My Top 10 Drug Development Abstracts at ASCO25
Oriol Mirallas, Medical Oncology Specialist at Vall d’Hebron Institute of Oncology, shared a post on X:
“Less than 72 hours for ASCO
Exciting science to be presented
New drugs into trials
Biespecific+/- ADC
ADC+ IO
KRASG12D
New small mol KIF18A
More ctDNA and new IAMy TOP 10 for Drug Development BELOW.”
Oriol Mirallas previewed the ASCO 2025 conference by highlighting promising innovations in drug development. Key trends include trials featuring bispecifics and ADC combinations, advances targeting KRASG12D, and novel agents like KIF18A inhibitors. He also emphasized increasing focus on ctDNA and immunoanalytics.
You Can Find More Posts Featuring Oriol Mirallas on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 30, 2025, 23:58
May 30, 2025, 20:19
May 30, 2025, 19:00